Gerald Cagle - Director, Clearside Biomedical, Inc

As of June 26, 2018


Gerald Cagle Net Worth

  • Net worth is estimated to be at least $472.94K
  • Owns at least 37,505 units of Clearside Biomedical, Inc stock
  • Sold an estimated value of $14 in the last 2 years at Clearside Biomedical, Inc

Gerald Cagle Trading

  • Largest purchase of shares was 14,064 units , worth over $99.85K on May 1, 2017
  • Largest sale of shares was 2 units , worth over $14 on June 7, 2016
  • In total has made about 10 transactions over 2 years
  • Usually trades in June, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Gerald Cagle Mailing Address

  • Mailing address is 135 U.S. Highway 206 Suite 15 Bedminster NJ 07921 NJ

Clearside Biomedical, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
George Lasezkay 2020 $503,313 $286,513 $402,827 $163,577 $14,777 $1,371,007
George Lasezkay 2019 $371,235 $181,772 $299,915 $159,809 $32,461 $1,045,192
Charles A. Deignan 2020 $342,876 $59,250 $152,010 $78,004 $9,450 $641,590
Charles A. Deignan 2019 $332,890 $105,264 $107,753 $106,000 $9,300 $661,207
Thomas Ciulla 2020 $367,375 $59,250 $152,010 $83,578 $9,450 $671,663
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1539029/000119312521135345/d59948ddef14a.htm

Clearside Biomedical, Inc Insider Trading

  • The most recent transaction was 2,560 units sold on September 23, 2021 by Thomas Ciulla worth over $16.38K
  • In the last 5 years, insiders at Clearside Biomedical, Inc sold an estimated value of $11.81M and bought an estimated value of $13.77M
  • The most active traders are Clay Thorp, Director,  Charles Deignan, Chief Financial Officer,  and George Lasezkay, CEO
  • Insider trading is most common in June, with the busiest year in 2017

Clearside Biomedical, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1